68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

By W. Fendler, M. Eiber, M. Beheshti, J. Bomanji, F. Ceci, Steven Cho, F. Giesel, U. Haberkorn, T. Hope, K. Kopka and 8 more. European Journal of Nuclear Medicine and Molecular Imaging, 2017

630 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/7edf5effd82262643d42a45b429b2906dd83e029

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. K. Fizazi
2. T. Beer
3. M. Morris
4. O. Sartor
5. K. Chi
6. J. D. de Bono
7. K. Rahbar
8. L. Nordquist

Citations in the corpus

• Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. (2019, neutral): “Confirmed (per-region) 84 76 (90)a 8 (10)b 0.”
• Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer (2021, background): “279 (191) Discontinued 177Lu-PSMA-617 127 (91) Had progressive disease 54 (35) Had adverse event 36 (27) Had lack of clinical benefit 23 (8) Withdrew consent to treatment 16 (12) Were withdrawn by investigator 14 (11) Died 6 (4) Received prohibited therapy 2 (2) Had other reason 1 (1) Was lost to fo”